...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation
【24h】

Low rate of atrial fibrillation recurrence verified by implantable loop recorder monitoring following a convergent epicardial and endocardial ablation of atrial fibrillation

机译:心房纤颤和心内膜融合消融后植入式记录仪监测证实房颤复发率低

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Implantable Loop Recorder Monitoring Outcomes for the Convergent AF Procedure. Objective: Evaluate long-term outcomes in patients undergoing the Convergent procedure (CP) for the treatment of atrial fibrillation (AF). Background: The CP provides a multidisciplinary approach, combining endoscopic creation of epicardial linear lesions followed by endocardial mapping and ablation and targets persistent and longstanding persistent AF patients who are at increased risk of heart failure, stroke, and mortality. Methods: Outcomes from a prospective nonrandomized study were recorded for consecutive patients by interrogation of implanted Reveal? monitors. Rhythm status and AF burden were quantified 6-24 months postprocedure, and compared relative to AF type, gender, age, body mass index, left atrial size, left ventricular ejection fraction, and congestive heart failure, hypertension, age 75 years, age between 65 and 74 years, stroke/TIA/TE, vascular disease (previous MI, peripheral arterial disease or aortic plaque), diabetes mellitus, female (CHA 2DS 2VASc). Results: A total of 50 patients were enrolled with 94% having persistent or longstanding persistent AF. There were 2 atrioesophageal fistulas reported. In one patient, the fistula resulted in death at 33 days postprocedure; in the second, the fistula was surgically repaired but patient died 8 months postprocedure from a CVI. After CP, 95% of patients were in sinus rhythm at 6-month follow-up; 88% at 12 months; and 87% at 24 months. The median AF burden recorded with Reveal XT monitors was 0.0%, 0.1%, and 0.1% at 6, 12, and 24 months with 81%, 81%, and 87% of patients reporting a burden less than 3%, respectively. Conclusion: Using 24 × 7 continuous loop recording, the CP demonstrated success in treating persistent and longstanding persistent AF patients. Endocardial mapping and catheter ablation with diagnostic confirmation of procedural success complemented the endoscopic creation of epicardial linear lesions in restoring sinus rhythm.
机译:收敛性AF程序的植入式循环记录仪监视结果。目的:评估接受融合疗法(CP)治疗房颤(AF)的患者的长期结局。背景:CP提供了一种多学科的方法,将内镜下心外膜线性病变的产生,心内膜标测和消融相结合,并针对那些心衰,中风和死亡风险增加的持续性和长期持续性AF患者。方法:通过询问植入的Reveal?来记录连续患者的前瞻性非随机研究结果。显示器。术后6-24个月量化心律状态和房颤负担,并与房颤类型,性别,年龄,体重指数,左心房大小,左心室射血分数和充血性心力衰竭,高血压,年龄> 75岁,年龄进行比较65岁至74岁之间,中风/ TIA / TE,血管疾病(先前的MI,周围动脉疾病或主动脉斑块),糖尿病,女性(CHA 2DS 2VASc)。结果:共纳入50例患者,其中94%患有持续性或长期持续性AF。有2例食管食管瘘。一名患者的瘘管在手术后33天死亡。在第二例中,通过外科手术修复了瘘管,但患者在术后8个月因CVI死亡。 CP后6个月的随访中95%的患者有窦性心律; 12个月时为88%;在24个月时占87%。在6、12和24个月时,Reveal XT监护仪记录的中位AF负荷分别为0.0%,0.1%和0.1%,其中81%,81%和87%的患者报告的负荷少于3%。结论:通过24×7连续循环记录,CP证明成功治疗了持续性和长期性持续性AF患者。心内膜标测和导管消融术对手术成功进行了诊断证实,可在内窥镜下创建心外膜线性病变,以恢复窦性心律。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号